External Email - Use Caution        

Hello FreeSurfer experts,

I am currently working through the linear mixed effects pipeline to assess 
longitudinal cortical thickness changes in non-contact/contact athletes and 
have some questions. My design matrix is as follows:
X = [ones(size(M,1), 1), M(:,1), M(:,2), M(:,3), M(:,1).*M(:,3), M(:,4), 
M(:,1).*M(:,4), M(:,5), M(:,6), M(:,7), M(:,8), M(:,9)];
M(:,1) = group
M(:,2) = scan time from baseline
M(:,3) = age
With the rest of the columns in X being other covariates from M or *time 
interaction, and the random intercept term being the only random effect.


  1.  I'm using the spatiotemporal approach, but would vertex-wise yield more 
powerful results? I know that a previous thread had a similar question, but I 
am wondering if one would be more favourable for looking at regional CT changes.
  2.  As well, the two groups have different distributions in timepoints and 
size. The contact athlete group is about double the size (42 vs 21) and has 
significantly more athletes with multi-year participation (2- or 3-years), 
whereas the non-contact athlete group is almost entirely single-year 
participation (one set of pre- and post-season scans). Is this something that 
the LME can inherently account for?
  3.  My main goal is to test if there is a significant difference in the 
slopes of the two groups (using lme_mass_F). I currently have this setup for my 
contrast matrix: CM.C = [0 1 zeros(1,10)]. Since I only have two groups, is it 
logical to use a single row? Additionally, I am a bit unsure of how to assign 
beta weights.
  4.  After running the F-test, I am correcting the multiple comparisons using 
FDR2. Are there any other corrections/tests I should utilize before plotting 
data in tksurfer?


Thank you in advance,
Daniel
_______________________________________________
Freesurfer mailing list
Freesurfer@nmr.mgh.harvard.edu
https://mail.nmr.mgh.harvard.edu/mailman/listinfo/freesurfer
The information in this e-mail is intended only for the person to whom it is 
addressed.  If you believe this e-mail was sent to you in error and the e-mail 
contains patient information, please contact the Mass General Brigham 
Compliance HelpLine at https://www.massgeneralbrigham.org/complianceline 
<https://www.massgeneralbrigham.org/complianceline> .
Please note that this e-mail is not secure (encrypted).  If you do not wish to 
continue communication over unencrypted e-mail, please notify the sender of 
this message immediately.  Continuing to send or respond to e-mail after 
receiving this message means you understand and accept this risk and wish to 
continue to communicate over unencrypted e-mail. 

Reply via email to